5D63
MOA-Z-VAD-fmk inhibitor complex, direct/inverted dual orientation
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-07-16 |
Detector | MARMOSAIC 325 mm CCD |
Wavelength(s) | 0.873 |
Spacegroup name | P 63 2 2 |
Unit cell lengths | 121.066, 121.066, 99.950 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 46.420 - 1.650 |
R-factor | 0.16294 |
Rwork | 0.162 |
R-free | 0.18716 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3ef2 |
RMSD bond length | 0.023 |
RMSD bond angle | 2.114 |
Data reduction software | XDS (VERSION September 26, 2012) |
Data scaling software | XDS |
Phasing software | PHASER (2.5.1) |
Refinement software | REFMAC (5.7.0029) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.420 | 1.750 |
High resolution limit [Å] | 1.650 | 1.650 |
Rmerge | 0.120 | 0.540 |
Number of reflections | 48993 | |
<I/σ(I)> | 11.3 | 2 |
Completeness [%] | 93.5 | 70.5 |
Redundancy | 7.2 | 4.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 293.15 | 0.1 M imidazole pH 8.0, 16% PEG 8000, 5% DMSO, 0.2 M calcium acetate |